PMED — Predictmedix AI Cashflow Statement
0.000.00%
- CA$3.85m
- CA$3.85m
- 10
- 10
- 52
- 12
Annual cashflow statement for Predictmedix AI, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.58 | -1.88 | -2.07 | -1.99 | -1.18 |
Depreciation | |||||
Non-Cash Items | 0.579 | 0.219 | 0.518 | 0.365 | 0.191 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.078 | 0.051 | 0.856 | -0.182 | 0.792 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.08 | -1.53 | -0.534 | -1.64 | -0.037 |
Capital Expenditures | -0.195 | -0.418 | -0.145 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Sale of Business | |||||
Cash from Investing Activities | -0.195 | -0.418 | -0.145 | 0 | — |
Financing Cash Flow Items | 0 | -0.004 | 0.017 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.261 | 1.68 | 0.547 | 1.6 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.01 | -0.269 | -0.132 | -0.042 | -0.037 |